跳至主要内容
临床试验/NCT03363425
NCT03363425Unknown2 期

Effect of Perioperative Intravenous Infusion of Dexmedetomidine vs. Lidocaine on Postoperative Pain, Analgesic Consumption, Bowel Function and Recovery After Abdominal Gynaecological Surgery: a Randomised Double Blind Study

University of Athens1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2017年11月14日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
发起方
入组人数
60
试验地点
1
主要终点
analgesic consumption 24 hours postop

研究概览

简要总结

Postoperative pain continues to be inadequately managed and is the most common reason for the delay in discharge and unplanned hospital admission after surgery. Opioids remain the mainstay for postoperative analgesia. However, there is a continuous search for adjuvant therapies to reduce the doses of opioids and their related adverse effects, and extend the use of non-opioid analgesia for acute pain after abdominal surgery, thereby improving patient recovery. Currently there are no clinical trials that investigate the effect of intravenous lidocaine vs dexmedetomidine on postoperative pain, analgesic consumption and bowel function of patients undergoing abdominal gynaecological surgery. Purpose of this prospective double blind randomised clinical trial is the investigation of the effect of perioperative intravenous infusion of lidocaine vs dexmedetomidine vs placebo (Normal Saline 0,9%) on analgesic parameters and functional recovery of patients undergoing abdominal gynaecological surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
30 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 30-70 years
  • abdominal gynaecological surgery

排除标准

  • patient's refusal
  • contraindication to the use of local anesthetics
  • body mass index >30 kg/m2
  • history of cardiovascular diseases/ arrhythmias/ conduction abnormalities
  • pregnant women
  • significant renal or hepatic impairment
  • insulin-dependent diabetes mellitus
  • central nervous system disease or psychiatric diseases
  • chronic use of opioids, steroids, clonidine (or other a2 agonist)
  • use of drugs acting on the central nervous system or analgesics during the previous 2 weeks
  • drug/alcohol abuse
  • inability to comprehend the following pain assessment scale

研究组 & 干预措施

Lidocaine

Active Comparator

干预措施: Lidocaine Iv (Drug)

Dexmedetomidine

Active Comparator

干预措施: Dexmedetomidine (Drug)

Normal Saline 0,9%

Placebo Comparator

干预措施: Normal saline (Drug)

结局指标

主要结局

analgesic consumption 24 hours postop

时间窗: 24 hours postoperatively

morphine consumption from PCA

次要结局

  • postoperative pain(48 hours postoperatively)

研究者

发起方
University of Athens
申办方类型
Other
责任方
Principal Investigator
主要研究者

Staikou Chryssoula

Assistant Professor of Anaesthesiology

University of Athens

研究点 (1)

Loading locations...

相似试验